or Try an Advanced Search...

    Cd20 Stocks List

    Symbol Grade Name % Change
    BIIB C Biogen Idec Inc. -1.13
    GMAB F Genmab A/S 0.90
    TGTX C TG Therapeutics, Inc. 4.06
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Long-Term Care Facilities
    Related Stock Lists: Lymphoma Monoclonal Antibodies Monoclonal Antibody Antibody Drug Conjugate Biotechnology Camidanlumab Tesirine Cancer Chronic Lymphocytic Leukemia Immunology Lymphocytic Leukemia Medicine Multiple Sclerosis Treatment Of Cancer Acute Myeloid Leukemia Advanced Cancer Advanced Cancers Alzheimer's Disease Amyloid Amyloidosis Antibodies

    Related ETFs - A few ETFs which own one or more of the above listed Cd20 stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 8.31
    FBT D First Trust Amex Biotech Index Fund 6.92
    BIS D ProShares UltraShort Nasdaq Biotechnology 6.12
    IBB D iShares Nasdaq Biotechnology Index Fund 4.79
    BBH C Market Vectors Biotech ETF 4.51
    View all Cd20 ETFs...
    Compare ETFs
    Compare BIS to BBH Compare FBT to BBH Compare FBT to IBB

        Cd20 Stocks Recent News

        Date Stock Title
        May 4 BIIB Morgan Stanley’s Top 15 Stock Picks for 2024
        May 3 GMAB Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
        May 3 TGTX TG Therapeutics: Less Room For Doubt About Briumvi
        May 3 TGTX TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
        May 3 TGTX Rainbows and Unicorns: TG Therapeutics, Inc. (NASDAQ:TGTX) Analysts Just Became A Lot More Optimistic
        May 3 TGTX Why TG Therapeutics Stock Was Rocketing Higher This Week
        May 3 TGTX TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript
        May 2 GMAB Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript
        May 2 GMAB Genmab A/S 2024 Q1 - Results - Earnings Call Presentation
        May 2 GMAB Genmab reports Q1 results
        May 2 GMAB Genmab Announces Financial Results for the First Quarter of 2024
        May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
        May 2 TGTX TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 2 TGTX TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ...
        May 2 TGTX Q1 2024 TG Therapeutics Inc Earnings Call
        May 1 GMAB Genmab Q1 2024 Earnings Preview
        May 1 GMAB Genmab: A Complicated Tale
        May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
        May 1 TGTX TG Therapeutics jumps as Q1 Briumvi sales top guidance
        May 1 TGTX TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
        Related Industries: Biotechnology Drug Manufacturers - Major Long-Term Care Facilities
        Related Stock Lists: Lymphoma Monoclonal Antibodies Monoclonal Antibody Antibody Drug Conjugate Biotechnology Camidanlumab Tesirine Cancer Chronic Lymphocytic Leukemia Immunology Lymphocytic Leukemia Medicine Multiple Sclerosis Treatment Of Cancer Acute Myeloid Leukemia Advanced Cancer Advanced Cancers Alzheimer's Disease Amyloid Amyloidosis Antibodies
        Cd20

        Browse All Tags